Equillium, Inc. (EQ)
EQ
Loading signal…
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $83M
- Short % float
- 31.58%
- Days to cover
- 6.0
- SI change
- +0.7%
- 1W
- +3.45%
- 1M
- -28.91%
- vs SPY 1W
- +3.03%
- vs SPY 1M
- -30.97%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FAQ
- What is LOPJLB’s current signal on EQ?
- LOPJLB publishes daily direction and regime signals for EQ on this page.
- What market regime is EQ in?
- LOPJLB classifies each ticker into BULL, RECOVERY, BEAR, or CRISIS regimes using a Hidden Markov Model.
- What does Equillium, Inc. (EQ) do?
- Equillium, Inc. is a clinical-stage biopharmaceutical company focused on developing and bringing to market products designed to address severe autoimmune and inflammatory (immuno-inflammatory) disorders where current treatment options are insufficient. The company's primary drug candidate is itolizumab (EQ001), a monoclonal antibody in clinical development that targets the novel CD6 immune chec…